Sangers Sequencing Service Comprehensive Study by Application (Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Forensics, Other), Laboratory (Web Lab, Dry Lab), Services class (Single Pass, Bi-directional, Culture, Primer Walking Single Direction, Primer Walking Bi-Direction, Applied Genomics Services), End User (Pharmaceutical & biotechnology companies, Academic & research institutes, Others) Players and Region - Global Market Outlook to 2027

Sangers Sequencing Service Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Sangers Sequencing Service?
The healthcare industry aims to advance technology to reduce health problems and to extend the lifespan of human beings. Therefore, international brands, as well as thousands of biotechnology start-ups across the globe, are aiming to contribute to humanity by developing new technologies for the healthcare sector. Sangers Sequencing Service is a method of DNA sequencing based on the selective incorporation of chain-terminating dideoxynucleotides by DNA polymerase during in vitro DNA replication. The most widely used testing platform for mutation detection in various cancer settings, as it provides a comprehensive examination of all genetic aberrations in the sample material. Sanger sequencing has proven useful for assessing the presence or absence of recurrent single nucleotide mutations or small insertions/deletions in oncogenes and tumor suppressor genes in surgically resected pathology specimens. The field of genomics has surpassed expectations over the past three decades due to massive changes in technology that allowed researchers to interrogate larger pieces of the human genome.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledGenScript Biotech Corporation (United States), Source BioScience (United Kingdom), LGC Science Group Limited (United Kingdom), Thermo Fisher Scientific, Inc. (United States), Quintara Biosciences (United States), Fasteris SA (Switzerland), GENEWIZ (United States), GenHunter Corporation (United States), SciGenom Labs Pvt. Limited(United States) and Nucleics (Australia)


The study covers a detailed analysis segmented by key business segments i.e. , by application (Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Forensics and Other) and major geographies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Sangers Sequencing Service market throughout the predicted period.

The competition is expected to become even more intense in the years to come due to the entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the market’s competitive landscape and offers information on the products offered by various leading companies. Additionally, this Sangers Sequencing Service market report suggests strategies that Players can follow and highlights key areas they should focus on, in order to take maximum benefits of growth opportunities.

The report offers several leading Players, some of them are GenScript Biotech Corporation (United States), Source BioScience (United Kingdom), LGC Science Group Limited (United Kingdom), Thermo Fisher Scientific, Inc. (United States), Quintara Biosciences (United States), Fasteris SA (Switzerland), GENEWIZ (United States), GenHunter Corporation (United States), SciGenom Labs Pvt. Limited(United States) and Nucleics (Australia).

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.

Market Trend
Technological advancements in Sanger’s sequencing
Restraints
  • Sanger sequencing has been replaced by Next-Generation sequencing methods

Opportunities
Growing genomics research in academic and research institutes and outsourcing of genome testing in biopharmaceutical & biotechnology industry to drive the adoption of Sangers Sequencing Service services, thus propelling the Sangers Sequencing Service services market.

Key highlights of the Global Sangers Sequencing Service market Study:
• CAGR of the market during the forecast period 2021-2027
• In-depth information on growth factors that will accelerate the Sangers Sequencing Service market in next few years.
• Detailed Insights on futuristic trends and changing consumer behaviour
• Forecast of the Global Sangers Sequencing Service market size and its contribution to the parent market by type, application and by country.
• A broad view of customer demand
• Uncover market’s competitive landscape and in-depth information on various Players
• Comprehensive information about factors that will challenge the growth of Sangers Sequencing Service Players

Transformation and Important Triggers:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
• A tipping point in globalization
• A major slowdown in Western economies
• Significant shifts in technology and cost structure
• The challenges of regulatory compliance
• New forms of competition developing

Research Methodology:

The top-down and bottom-up approaches are used to estimate and validate the size of the Global Sangers Sequencing Service market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, and SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Sangers Sequencing Service market.
In order to make a priority list sorting is done based on revenue generated based on the latest reporting, using paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Sangers Sequencing Service Provider, Government Regulatory and Research Organizations and End-Use Industry.
This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases, etc.

Report Objectives / Segmentation Covered

By Application
  • Diagnostics
  • Biomarkers and Cancer
  • Reproductive Health
  • Personalized Medicine
  • Forensics
  • Other
By Laboratory
  • Web Lab
  • Dry Lab

By Services class
  • Single Pass
  • Bi-directional
  • Culture
  • Primer Walking Single Direction
  • Primer Walking Bi-Direction
  • Applied Genomics Services

By End User
  • Pharmaceutical & biotechnology companies
  • Academic & research institutes
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Start-Up Companies for Genome Analysis
      • 3.2.2. The surge in applications of Sanger’s sequencing has boosted the growth of the global Sanger’s sequencing service market
    • 3.3. Market Challenges
      • 3.3.1. Lack of skilled professionals and standardization concerns over sequencing-based diagnostics hamper the market
    • 3.4. Market Trends
      • 3.4.1. Technological advancements in Sanger’s sequencing
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Sangers Sequencing Service, by Application, Laboratory, Services class, End User and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Sangers Sequencing Service (Value)
      • 5.2.1. Global Sangers Sequencing Service by: Application (Value)
        • 5.2.1.1. Diagnostics
        • 5.2.1.2. Biomarkers and Cancer
        • 5.2.1.3. Reproductive Health
        • 5.2.1.4. Personalized Medicine
        • 5.2.1.5. Forensics
        • 5.2.1.6. Other
      • 5.2.2. Global Sangers Sequencing Service by: Laboratory (Value)
        • 5.2.2.1. Web Lab
        • 5.2.2.2. Dry Lab
      • 5.2.3. Global Sangers Sequencing Service by: Services class (Value)
        • 5.2.3.1. Single Pass
        • 5.2.3.2. Bi-directional
        • 5.2.3.3. Culture
        • 5.2.3.4. Primer Walking Single Direction
        • 5.2.3.5. Primer Walking Bi-Direction
        • 5.2.3.6. Applied Genomics Services
      • 5.2.4. Global Sangers Sequencing Service by: End User (Value)
        • 5.2.4.1. Pharmaceutical & biotechnology companies
        • 5.2.4.2. Academic & research institutes
        • 5.2.4.3. Others
      • 5.2.5. Global Sangers Sequencing Service Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Sangers Sequencing Service: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. GenScript Biotech Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Source BioScience (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. LGC Science Group Limited (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Quintara Biosciences (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Fasteris SA (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. GENEWIZ (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. GenHunter Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. SciGenom Labs Pvt. Limited(United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Nucleics (Australia)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Sangers Sequencing Service Sale, by Application, Laboratory, Services class, End User and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Sangers Sequencing Service (Value)
      • 7.2.1. Global Sangers Sequencing Service by: Application (Value)
        • 7.2.1.1. Diagnostics
        • 7.2.1.2. Biomarkers and Cancer
        • 7.2.1.3. Reproductive Health
        • 7.2.1.4. Personalized Medicine
        • 7.2.1.5. Forensics
        • 7.2.1.6. Other
      • 7.2.2. Global Sangers Sequencing Service by: Laboratory (Value)
        • 7.2.2.1. Web Lab
        • 7.2.2.2. Dry Lab
      • 7.2.3. Global Sangers Sequencing Service by: Services class (Value)
        • 7.2.3.1. Single Pass
        • 7.2.3.2. Bi-directional
        • 7.2.3.3. Culture
        • 7.2.3.4. Primer Walking Single Direction
        • 7.2.3.5. Primer Walking Bi-Direction
        • 7.2.3.6. Applied Genomics Services
      • 7.2.4. Global Sangers Sequencing Service by: End User (Value)
        • 7.2.4.1. Pharmaceutical & biotechnology companies
        • 7.2.4.2. Academic & research institutes
        • 7.2.4.3. Others
      • 7.2.5. Global Sangers Sequencing Service Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Sangers Sequencing Service: by Application(USD Million)
  • Table 2. Sangers Sequencing Service Diagnostics , by Region USD Million (2016-2021)
  • Table 3. Sangers Sequencing Service Biomarkers and Cancer , by Region USD Million (2016-2021)
  • Table 4. Sangers Sequencing Service Reproductive Health , by Region USD Million (2016-2021)
  • Table 5. Sangers Sequencing Service Personalized Medicine , by Region USD Million (2016-2021)
  • Table 6. Sangers Sequencing Service Forensics , by Region USD Million (2016-2021)
  • Table 7. Sangers Sequencing Service Other , by Region USD Million (2016-2021)
  • Table 8. Sangers Sequencing Service: by Laboratory(USD Million)
  • Table 9. Sangers Sequencing Service Web Lab , by Region USD Million (2016-2021)
  • Table 10. Sangers Sequencing Service Dry Lab , by Region USD Million (2016-2021)
  • Table 11. Sangers Sequencing Service: by Services class(USD Million)
  • Table 12. Sangers Sequencing Service Single Pass , by Region USD Million (2016-2021)
  • Table 13. Sangers Sequencing Service Bi-directional , by Region USD Million (2016-2021)
  • Table 14. Sangers Sequencing Service Culture , by Region USD Million (2016-2021)
  • Table 15. Sangers Sequencing Service Primer Walking Single Direction , by Region USD Million (2016-2021)
  • Table 16. Sangers Sequencing Service Primer Walking Bi-Direction , by Region USD Million (2016-2021)
  • Table 17. Sangers Sequencing Service Applied Genomics Services , by Region USD Million (2016-2021)
  • Table 18. Sangers Sequencing Service: by End User(USD Million)
  • Table 19. Sangers Sequencing Service Pharmaceutical & biotechnology companies , by Region USD Million (2016-2021)
  • Table 20. Sangers Sequencing Service Academic & research institutes , by Region USD Million (2016-2021)
  • Table 21. Sangers Sequencing Service Others , by Region USD Million (2016-2021)
  • Table 22. South America Sangers Sequencing Service, by Country USD Million (2016-2021)
  • Table 23. South America Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 24. South America Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 25. South America Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 26. South America Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 27. Brazil Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 28. Brazil Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 29. Brazil Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 30. Brazil Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 31. Argentina Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 32. Argentina Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 33. Argentina Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 34. Argentina Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 35. Rest of South America Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 36. Rest of South America Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 37. Rest of South America Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 38. Rest of South America Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 39. Asia Pacific Sangers Sequencing Service, by Country USD Million (2016-2021)
  • Table 40. Asia Pacific Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 41. Asia Pacific Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 42. Asia Pacific Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 43. Asia Pacific Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 44. China Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 45. China Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 46. China Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 47. China Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 48. Japan Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 49. Japan Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 50. Japan Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 51. Japan Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 52. India Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 53. India Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 54. India Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 55. India Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 56. South Korea Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 57. South Korea Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 58. South Korea Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 59. South Korea Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 60. Taiwan Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 61. Taiwan Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 62. Taiwan Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 63. Taiwan Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 64. Australia Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 65. Australia Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 66. Australia Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 67. Australia Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 68. Rest of Asia-Pacific Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 69. Rest of Asia-Pacific Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 70. Rest of Asia-Pacific Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 71. Rest of Asia-Pacific Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 72. Europe Sangers Sequencing Service, by Country USD Million (2016-2021)
  • Table 73. Europe Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 74. Europe Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 75. Europe Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 76. Europe Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 77. Germany Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 78. Germany Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 79. Germany Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 80. Germany Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 81. France Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 82. France Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 83. France Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 84. France Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 85. Italy Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 86. Italy Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 87. Italy Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 88. Italy Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 89. United Kingdom Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 90. United Kingdom Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 91. United Kingdom Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 92. United Kingdom Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 93. Netherlands Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 94. Netherlands Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 95. Netherlands Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 96. Netherlands Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 97. Rest of Europe Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 98. Rest of Europe Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 99. Rest of Europe Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 100. Rest of Europe Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 101. MEA Sangers Sequencing Service, by Country USD Million (2016-2021)
  • Table 102. MEA Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 103. MEA Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 104. MEA Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 105. MEA Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 106. Middle East Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 107. Middle East Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 108. Middle East Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 109. Middle East Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 110. Africa Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 111. Africa Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 112. Africa Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 113. Africa Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 114. North America Sangers Sequencing Service, by Country USD Million (2016-2021)
  • Table 115. North America Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 116. North America Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 117. North America Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 118. North America Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 119. United States Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 120. United States Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 121. United States Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 122. United States Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 123. Canada Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 124. Canada Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 125. Canada Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 126. Canada Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 127. Mexico Sangers Sequencing Service, by Application USD Million (2016-2021)
  • Table 128. Mexico Sangers Sequencing Service, by Laboratory USD Million (2016-2021)
  • Table 129. Mexico Sangers Sequencing Service, by Services class USD Million (2016-2021)
  • Table 130. Mexico Sangers Sequencing Service, by End User USD Million (2016-2021)
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Sangers Sequencing Service: by Application(USD Million)
  • Table 142. Sangers Sequencing Service Diagnostics , by Region USD Million (2022-2027)
  • Table 143. Sangers Sequencing Service Biomarkers and Cancer , by Region USD Million (2022-2027)
  • Table 144. Sangers Sequencing Service Reproductive Health , by Region USD Million (2022-2027)
  • Table 145. Sangers Sequencing Service Personalized Medicine , by Region USD Million (2022-2027)
  • Table 146. Sangers Sequencing Service Forensics , by Region USD Million (2022-2027)
  • Table 147. Sangers Sequencing Service Other , by Region USD Million (2022-2027)
  • Table 148. Sangers Sequencing Service: by Laboratory(USD Million)
  • Table 149. Sangers Sequencing Service Web Lab , by Region USD Million (2022-2027)
  • Table 150. Sangers Sequencing Service Dry Lab , by Region USD Million (2022-2027)
  • Table 151. Sangers Sequencing Service: by Services class(USD Million)
  • Table 152. Sangers Sequencing Service Single Pass , by Region USD Million (2022-2027)
  • Table 153. Sangers Sequencing Service Bi-directional , by Region USD Million (2022-2027)
  • Table 154. Sangers Sequencing Service Culture , by Region USD Million (2022-2027)
  • Table 155. Sangers Sequencing Service Primer Walking Single Direction , by Region USD Million (2022-2027)
  • Table 156. Sangers Sequencing Service Primer Walking Bi-Direction , by Region USD Million (2022-2027)
  • Table 157. Sangers Sequencing Service Applied Genomics Services , by Region USD Million (2022-2027)
  • Table 158. Sangers Sequencing Service: by End User(USD Million)
  • Table 159. Sangers Sequencing Service Pharmaceutical & biotechnology companies , by Region USD Million (2022-2027)
  • Table 160. Sangers Sequencing Service Academic & research institutes , by Region USD Million (2022-2027)
  • Table 161. Sangers Sequencing Service Others , by Region USD Million (2022-2027)
  • Table 162. South America Sangers Sequencing Service, by Country USD Million (2022-2027)
  • Table 163. South America Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 164. South America Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 165. South America Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 166. South America Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 167. Brazil Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 168. Brazil Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 169. Brazil Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 170. Brazil Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 171. Argentina Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 172. Argentina Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 173. Argentina Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 174. Argentina Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 175. Rest of South America Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 176. Rest of South America Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 177. Rest of South America Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 178. Rest of South America Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 179. Asia Pacific Sangers Sequencing Service, by Country USD Million (2022-2027)
  • Table 180. Asia Pacific Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 181. Asia Pacific Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 182. Asia Pacific Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 183. Asia Pacific Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 184. China Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 185. China Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 186. China Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 187. China Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 188. Japan Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 189. Japan Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 190. Japan Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 191. Japan Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 192. India Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 193. India Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 194. India Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 195. India Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 196. South Korea Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 197. South Korea Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 198. South Korea Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 199. South Korea Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 200. Taiwan Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 201. Taiwan Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 202. Taiwan Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 203. Taiwan Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 204. Australia Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 205. Australia Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 206. Australia Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 207. Australia Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 208. Rest of Asia-Pacific Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 209. Rest of Asia-Pacific Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 210. Rest of Asia-Pacific Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 211. Rest of Asia-Pacific Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 212. Europe Sangers Sequencing Service, by Country USD Million (2022-2027)
  • Table 213. Europe Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 214. Europe Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 215. Europe Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 216. Europe Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 217. Germany Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 218. Germany Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 219. Germany Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 220. Germany Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 221. France Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 222. France Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 223. France Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 224. France Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 225. Italy Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 226. Italy Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 227. Italy Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 228. Italy Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 229. United Kingdom Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 230. United Kingdom Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 231. United Kingdom Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 232. United Kingdom Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 233. Netherlands Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 234. Netherlands Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 235. Netherlands Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 236. Netherlands Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 237. Rest of Europe Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 238. Rest of Europe Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 239. Rest of Europe Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 240. Rest of Europe Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 241. MEA Sangers Sequencing Service, by Country USD Million (2022-2027)
  • Table 242. MEA Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 243. MEA Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 244. MEA Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 245. MEA Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 246. Middle East Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 247. Middle East Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 248. Middle East Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 249. Middle East Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 250. Africa Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 251. Africa Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 252. Africa Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 253. Africa Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 254. North America Sangers Sequencing Service, by Country USD Million (2022-2027)
  • Table 255. North America Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 256. North America Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 257. North America Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 258. North America Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 259. United States Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 260. United States Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 261. United States Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 262. United States Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 263. Canada Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 264. Canada Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 265. Canada Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 266. Canada Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 267. Mexico Sangers Sequencing Service, by Application USD Million (2022-2027)
  • Table 268. Mexico Sangers Sequencing Service, by Laboratory USD Million (2022-2027)
  • Table 269. Mexico Sangers Sequencing Service, by Services class USD Million (2022-2027)
  • Table 270. Mexico Sangers Sequencing Service, by End User USD Million (2022-2027)
  • Table 271. Research Programs/Design for This Report
  • Table 272. Key Data Information from Secondary Sources
  • Table 273. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Sangers Sequencing Service: by Application USD Million (2016-2021)
  • Figure 5. Global Sangers Sequencing Service: by Laboratory USD Million (2016-2021)
  • Figure 6. Global Sangers Sequencing Service: by Services class USD Million (2016-2021)
  • Figure 7. Global Sangers Sequencing Service: by End User USD Million (2016-2021)
  • Figure 8. South America Sangers Sequencing Service Share (%), by Country
  • Figure 9. Asia Pacific Sangers Sequencing Service Share (%), by Country
  • Figure 10. Europe Sangers Sequencing Service Share (%), by Country
  • Figure 11. MEA Sangers Sequencing Service Share (%), by Country
  • Figure 12. North America Sangers Sequencing Service Share (%), by Country
  • Figure 13. Global Sangers Sequencing Service share by Players 2021 (%)
  • Figure 14. Global Sangers Sequencing Service share by Players (Top 3) 2021(%)
  • Figure 15. Global Sangers Sequencing Service share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. GenScript Biotech Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 18. GenScript Biotech Corporation (United States) Revenue: by Geography 2021
  • Figure 19. Source BioScience (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 20. Source BioScience (United Kingdom) Revenue: by Geography 2021
  • Figure 21. LGC Science Group Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. LGC Science Group Limited (United Kingdom) Revenue: by Geography 2021
  • Figure 23. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2021
  • Figure 25. Quintara Biosciences (United States) Revenue, Net Income and Gross profit
  • Figure 26. Quintara Biosciences (United States) Revenue: by Geography 2021
  • Figure 27. Fasteris SA (Switzerland) Revenue, Net Income and Gross profit
  • Figure 28. Fasteris SA (Switzerland) Revenue: by Geography 2021
  • Figure 29. GENEWIZ (United States) Revenue, Net Income and Gross profit
  • Figure 30. GENEWIZ (United States) Revenue: by Geography 2021
  • Figure 31. GenHunter Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 32. GenHunter Corporation (United States) Revenue: by Geography 2021
  • Figure 33. SciGenom Labs Pvt. Limited(United States) Revenue, Net Income and Gross profit
  • Figure 34. SciGenom Labs Pvt. Limited(United States) Revenue: by Geography 2021
  • Figure 35. Nucleics (Australia) Revenue, Net Income and Gross profit
  • Figure 36. Nucleics (Australia) Revenue: by Geography 2021
  • Figure 37. Global Sangers Sequencing Service: by Application USD Million (2022-2027)
  • Figure 38. Global Sangers Sequencing Service: by Laboratory USD Million (2022-2027)
  • Figure 39. Global Sangers Sequencing Service: by Services class USD Million (2022-2027)
  • Figure 40. Global Sangers Sequencing Service: by End User USD Million (2022-2027)
  • Figure 41. South America Sangers Sequencing Service Share (%), by Country
  • Figure 42. Asia Pacific Sangers Sequencing Service Share (%), by Country
  • Figure 43. Europe Sangers Sequencing Service Share (%), by Country
  • Figure 44. MEA Sangers Sequencing Service Share (%), by Country
  • Figure 45. North America Sangers Sequencing Service Share (%), by Country
List of companies from research coverage that are profiled in the study
  • GenScript Biotech Corporation (United States)
  • Source BioScience (United Kingdom)
  • LGC Science Group Limited (United Kingdom)
  • Thermo Fisher Scientific, Inc. (United States)
  • Quintara Biosciences (United States)
  • Fasteris SA (Switzerland)
  • GENEWIZ (United States)
  • GenHunter Corporation (United States)
  • SciGenom Labs Pvt. Limited(United States)
  • Nucleics (Australia)
Additional players considered in the study are as follows:
Microsynth AG. Inc. (Switzerland) , QIAGEN N.V. (Netherlands) , Illumina, Inc. (United States) , Macrogen, Inc. (South Korea) , Genotypic Technology Pvt. Ltd. (India) , Beijing Genomics Institute (China)
Select User Access Type

Key Highlights of Report


Jul 2022 162 Pages 91 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Sangers Sequencing Service Market is heading robustly to achieve new growth cycle.
The Concentration Rate of Global Sangers Sequencing Service market is dominated by United States Players and may generate healthy valuation by 2027.
  • Increasing Number of Start-Up Companies for Genome Analysis
  • The surge in applications of Sanger’s sequencing has boosted the growth of the global Sanger’s sequencing service market
dominated the Sangers Sequencing Service market. This is attributable to growing trend of "Technological advancements in Sanger’s sequencing"

Know More About Global Sangers Sequencing Service Market Report?